clinical trial · NCT06720714
A Study to Assess the Concentration of Rozanolixizumab in the Breast Milk of Healthy Lactating Women
UCB Biopharma SRL·phase1·completed·n = 15
Healthy ParticipantsRozanolixizumab
brief summary
The purpose of the study is to assess the concentration of rozanolixizumab in mature breast milk of healthy study participants following administration of a single dose of rozanolixizumab
started
Dec 3, 2024
primary completion
May 12, 2025
completion
May 12, 2025
last updated
Jun 4, 2026
official title
An Open-Label, Single-Dose Study to Assess the Concentration of Rozanolixizumab in the Breast Milk of Healthy Lactating Women
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol